LipoSwift LNP - In Vivo General Delivery Kit

The in vivo series is developed using proprietary lipid nanoparticle (LNP) technology, systematically designed to meet diverse in vivo nucleic acid application needs, achieving high delivery efficiency, precise targeting, and excellent biocompatibility. One of the key features of this series of kits is its ease of use while maintaining high transfection efficiency. It is designed for a simple, single-step encapsulation process that does not require any specific LNP encapsulation equipment.

The LipoSwift LNP - In Vivo General Delivery Kit provides a versatile and robust solution for delivering various types of nucleic acids to living organisms that can be utilized for a full range of in vivo applications. It is compatible with a wide array of nucleic acid types, including but not limited to mRNA, siRNA, saRNA, and circRNA, making it an incredibly flexible tool for various research scenarios, including efficacy validation, disease modeling, and vaccine delivery in animal studies. By integrating these capabilities, the kit empowers researchers to address complex project challenges with greater efficiency, reliability, and confidence. The kit is also designed to accommodate multiple administration routes, such as intravenous, intramuscular, intraperitoneal, subcutaneous, and intradermal injections. This flexibility makes it suitable for both systemic delivery and localized studies, ensuring precise adaptation to diverse experimental needs.

• Broad-Spectrum Nucleic Acid Delivery: The kit is compatible with multiple nucleic acid modalities, ensuring that one kit can serve diverse research needs without requiring separate formulations for each nucleic acid type.
• Flexible Administration Routes: The kit supports multiple injection routes, allowing researchers to match the delivery strategy to their experimental goals, whether systemic distribution or localized delivery is required.
• Single-Step Encapsulation Without Special Equipment: The kit enables encapsulation in one simple step using standard laboratory pipettes, drastically reducing the time and cost associated with LNP preparation.
• High Transfection Efficiency: Performance benchmarks show that LNPs prepared with the LipoSwift general delivery kit achieve transfection efficiencies comparable to LNPs made with professional encapsulation systems, ensuring that researchers do not compromise on data quality when opting for simplicity.
• Excellent Biocompatibility: The proprietary lipid composition of LipoSwift nanoparticles is optimized for low immunogenicity and high stability in physiological environments, ensuring minimal adverse effects and better tolerability in vivo.

LipoSwift LNP - In Vivo General Delivery Kit User Manual